A new study describes the complexity of the new T cell repertoire following immune-depleting therapy to treat multiple sclerosis, improving our understanding of immune tolerance and clinical outcomes. In the Immune Tolerance Network's ...
Tags: Immune System Reconstitutes Itself, Immune-Depleting Therapy
Adaptive Biotechnologies, a biotechnology company, has secured a $2.5m Phase II small business innovation research (SBIR) award from the National Heart, Lung, and Blood Institute, a division of the NIH. The award is granted to ...
Tags: Adaptive Biotechnologies, Medicine